Objective: The objective of this randomized, prospective, double-blind study was to compare nasal irrigation using hypertonic Dead Sea salt (DSS) solution with hypertonic saline in the treatment of chronic rhinosinusitis and improvement of quality of life (QOL). Methods: With Institutional Review Board approval, 42 adults seeking treatment for chronic rhinosinusitis in a tertiary university-affiliated medical center were studied. After history and endonasal examination, computed tomography imaging, and QOL survey (Standardized Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)]), patients were randomized to self-administered hypertonic saline spray and irrigation twice daily or hypertonic DSS spray and irrigation. Patients were reassessed weekly and at 1 month. Results: Both groups had similar symptoms and RQLQ(S) scores before treatment and had significant improvement after treatment. However, the DSS patients had significantly better symptom relief and only the DSS group showed improved RQLQ(S) scores. Conclusions: We present a shortterm study providing level I evidence on the superiority of DSS over saline nasal irrigation for treatment of chronic rhinosinusitis.
INTRODUCTION
Nasal saline irrigations are recognized as beneficial in reducing common symptoms of chronic rhinosinusitis. In addition to empiric evidence of its benefits, many scientific studies have been published proving its beneficial effects on clearing secretions, as well as its positive effects on the elimination of symptoms and its improving the quality of life for its users. Many formulations of the irrigant solution are commercially available, and each claims superiority. Pure saline solutions have been used as isotonic or hypertonic solutions and are considered the standard by which all other solutions must be measured.
One of the newer solutions now available is a solution of Dead Sea salts packaged as Oasis Nasal Irrigant and Oasis Nasal Spray. The DSS and water from the Dead Sea have long been recognized for their therapeutic benefits in treating recalcitrant dermatologic conditions such as severe psoriasis, which is resistant to standard treatment protocols. Dead Sea water has been shown to have significant antiinflammatory effects, and it is this property that is hypothesized to make it an ideal nasal irrigant. The purpose of this study is to produce level 1 evidence comparing the efficacy of DSS irrigation with saline irrigation in the elimination of chronic rhinosinusitis symptoms.
Study Design
This is a prospective, randomized, double-blind, controlled study conducted at a tertiary care institution. The authors and all others involved with the study have no financial interest in the product. Institutional Review Board approval was obtained. One hundred patients seeking otolaryngologic care for chronic rhinosinusitis symptoms were screened for this study. Fifty-seven patients were willing to enroll and signed the appropriate informed consent. Forty-two patients completed the study, and their data is the basis of this analysis.
MATERIALS AND METHODS

Inclusion Criteria
Patients considered as candidates for the study were seen in consultation for symptoms that persisted year-round and were present for more than 1 year. Adult male and female patients (ages 18 -56 years) were included. Typical symptoms included postnasal drainage, sinus pressure, nasal stuffiness, and headache, among others that are listed in Figure 1 . All patients had persistent symptoms after treatment with topical nasal steroids, decongestants, antihistamines, or antibiotic therapy when deemed appropriate. Patients with allergic and nonallergic rhi- nitis were included. Full endoscopic evaluation and computed tomography (CT) scan of the paranasal sinuses were performed on all patients. In an attempt to create a homogenous group of patients, the exclusion criteria were quite rigid and extensive.
Exclusion Criteria
Patients with endoscopic or CT evidence of acute sinusitis or polyps were excluded. Patients deemed candidates for endoscopic sinus surgery or nasal surgery because of obvious mechanical obstruction resulting from mucocele, polyps, or septal defects were also excluded. In addition, those patients with CT findings of complete opacification of any single sinus and those patients with allergic fungal sinusitis, cystic fibrosis, or any systemic disease that affects the immune system were excluded. Finally, patients known to be pregnant were excluded, but urinary chorionic gonadotropin levels were not measured on other patients.
Subjective and Objective Findings
Each patient underwent anterior rhinoscopy and nasal endoscopy before enrollment. Physical findings were recorded. The patient was then asked to complete a 16-point symptom questionnaire related to nasal and sinus disease (Fig. 1) . In addition, each patient was asked to complete the Standardized Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ[S]) focusing on the effects of nasal symptoms on seven domains.
Standardized Rhinoconjunctivitis Quality of Life Questionnaire
The RQLQ(S) was developed to measure the problems that adults with rhinoconjunctivitis, both atopic and nonatopic, experience as a result of their nose and eye symptoms. 1 It has 28 questions in seven domains (activity limitations, sleep problems, nonnose/eye symptoms, practical problems, nose symptoms, eye symptoms, and emotional function) and is available in both selfadministered and interviewer-administered formats. The selfadministered version, in English and Spanish, was used in the present study. Patients were asked to recall their experiences during the previous week and to give their responses on a 7-point scale. The questionnaire has excellent evaluative and discriminative properties, and has been used extensively throughout the world in a large number of clinical trials. The RQLQ(S) was administered before the initiation of treatment and after 4 weeks of treatment with either hypertonic saline or hypertonic DSS. The RQLQ(S) scores (based on "how troubled you have been during the last week as a result of your nose/eye symptoms" [0 ϭ not troubled to 6 ϭ extremely troubled]) of 28 individual questions categorized into seven domains were totaled to obtain domain and overall composite scores for baseline (before initiating treatment) and after 4 continuous weeks of treatment.
Treatment
The patients were then instructed on how to perform nasal irrigations, and were asked to do so every morning on arising and every night before going to sleep. They were also provided with a nasal spray identical to the irrigant, which they could use as needed. They were given supplies and irrigant for 60 days. Based on computer-generated random number assignment, the patients received either hypertonic DSS solution (1.8 N) or hypertonic saline irrigation (1.8 N). The experimental and control solutions were packaged identically. The patients were asked to return after 30 days.
Follow Up
On return, patients were each interviewed with respect to compliance and their nasal symptoms. They underwent repeat anterior rhinoscopy as well as nasal endoscopy. They were asked to complete the rhinosinusitis symptom questionnaire as well as the quality-of-life survey. Patients who did not return by day 45 were dropped from the study. Forty-two patients completed the study. Only after all the data was collected was the seal broken to identify the control versus the experimental group.
Statistical Analysis
All statistical analyses were performed using SPSS Version 11.0 (SPSS, Inc., Chicago, IL). Continuous data is displayed as mean Ϯ standard deviation (SD). Statistical significance was accepted when P Ͻ .05. The Levine's test for equality of variances was used to determine statistically significant variances. The paired Student t test was used to compare rhinitis severity scores and quality-of-life scores before and after treatment. The twotailed Student t test was used to identify differences in rhinitis severity scores and quality-of-life scores between treatment groups. The 2 test was used to test the association between categorical variables.
RESULTS
Fifty-seven adult patients were enrolled in the study. They signed informed consent forms and were randomized into the hypertonic saline group (16 males and 12 females with a mean age of 31.7 Ϯ 4.1 years) and the hypertonic DSS group (19 males and 10 females with a mean age of 32 Ϯ 2.9 years). Fifteen patients (8 hypertonic saline and 7 hypertonic DSS) were dropped from the study because of failure to comply with the protocol or failure to follow up satisfactorily. These groups did not differ in regard to age, male/female distribution, or dropout. Thus, 42 patients (29 males and 13 females) between the ages of 18 and 56 years (mean ϭ 31 Ϯ 3.3 years) were treated with either Fig. 1 . The 16-point symptom questionnaire related to nasal and sinus disease based on severity of disease (0 ϭ no discomfort to 3 ϭ severe discomfort) and totaled to obtain a composite score.
hypertonic saline (n ϭ 20) or hypertonic DSS (n ϭ 22) and completed the study.
Rhinosinusitis symptom scores, based on the severity (0 ϭ no discomfort to 3 ϭ severe discomfort) of 16 individual symptoms, were totaled to obtain composite scores for baseline (before initiating treatment) and after 4 continuous weeks of treatment. The mean baseline symptom score for the hypertonic saline group was 14.9 Ϯ 6.9 versus 17.4 Ϯ 8.4 for the hypertonic DSS group. There was no difference between these values (P ϭ .312). The mean baseline symptom score of the 15 patients who did not complete the study was 14.6 Ϯ 5.6. This value was not different from the mean baseline value in either the hypertonic DSS or the hypertonic saline groups. However, after 4 weeks of treatment, the mean symptom score for hypertonic saline was 15.2 Ϯ 8.6; this value was not different from baseline (P ϭ .851). In contrast, the mean symptom score for the hypertonic DSS group decreased significantly, to 7.7 Ϯ 5.9 (P Ͻ .001). The hypertonic DSS group mean composite rhinitis symptom score at 4 weeks was significantly lower than the 4-week score of the patients using hypertonic saline (P ϭ .003) (Fig. 2) . Twentyone of 22 patients (95.5%) treated with hypertonic DSS for 4 weeks demonstrated improved mean composite rhinitis scores as compared with 12 of 20 patients (60%) treated with 4 weeks of hypertonic saline.
The RQLQ(S) scores (based on "how troubled you have been during the last week as a result of your nose/eye symptoms" [0 ϭ not troubled to 6 ϭ extremely troubled]) of 28 individual questions categorized into seven domains were totaled to obtain composite scores for baseline (before initiating treatment) and after 4 continuous weeks of treatment. The mean baseline RQLQ(S) score for the hypertonic saline group was 63.5 Ϯ 36.7 versus 80.3 Ϯ 34.9 for the hypertonic DSS group. There was no difference between these values (P ϭ .137). However, after 4 weeks of treatment, the mean symptom score for the hypertonic saline group was 64.1 Ϯ 36.1; this value was not different from baseline (P ϭ .915). In contrast, the mean symptom score for the hypertonic DSS group decreased significantly, to 25.2 Ϯ 13.7 (P Ͻ .001). The hypertonic DSS group mean composite rhinitis symptom score at 4 weeks was significantly lower than the 4-week score in the hypertonic saline patients (P Ͻ .001) (Fig. 3) . All 22 patients (100%) treated with hypertonic DSS for 4 weeks demonstrated improved mean composite RQLQ(S) scores as compared with 8 of 20 patients (40%) treated with 4 weeks of hypertonic saline.
Regarding the individual RQLQ(S) domains, the mean baseline (before initiating treatment) scores were not different for activity, sleep, nonnose/eye symptoms, eye symptoms, and emotional domains. The baseline scores for practical problems and nasal symptoms were both significantly higher (more troubling) in the patients using hypertonic DSS as compared with the patients using hypertonic saline (10.2 Ϯ 4.9 vs. 6.5 Ϯ 3.7 for practical problems and 13.3 Ϯ 5.1 vs. 9.7 Ϯ 5.1 for nasal symptoms) ( Table I ). After 4 weeks of continuous treatment with either hypertonic saline or hypertonic DSS, all individual RQLQ(S) domain mean scores were significantly lower in the patients using hypertonic DDS as compared with the patients using hypertonic saline (Table II) .
DISCUSSION
Nasal irrigations have been used for centuries by otolaryngologists and rhinologists in the treatment of patients with allergic rhinitis and chronic rhinosinusitis. 2, 3 Recently, it has also been used in the postoperative care of patients with endoscopic sinus surgery. 4 Although the exact mechanism of action by which these nasal irrigations improve nasal function is not properly understood, most theories suggest that nasal irrigations: 1) improve the mucociliary function of the respiratory mucosa; 2) Fig. 2 . Change in rhinosinusitis symptom scores based on the severity (0 ϭ no discomfort to 3 ϭ severe discomfort) of 16 individual symptoms totaled to obtain composite scores for baseline (before initiating treatment) and after 4 continuous weeks of treatment. The asterisk denotes a statistically significant difference from baseline. The dagger denotes a statistically significant difference between groups. Fig. 3 . The Standardized Rhinoconjunctivitis Quality of Life Questionnaire scores based on "how troubled you have been during the last week as a result of your nose/eye symptoms" (0 ϭ not troubled to 6 ϭ extremely troubled). Twenty-eight individual questions categorized into seven domains totaled to obtain composite scores for baseline (before initiating treatment) and after 4 continuous weeks of treatment. The asterisk denotes a statistically significant difference from baseline. The dagger denotes a statistically significant difference between groups.
decrease the mucosal edema; 3) help to clear static secretions; 4) rinse infective debris; 5) remove the source of allergen; and 6) minimize crusting, which may obstruct normal sinonasal drainage or lead to adhesions. 5 Nasal irrigation treatment is not a substitute for surgical intervention and it is not a substitute for allergic and medical management. Despite our best efforts, millions of Americans experience symptoms of chronic rhinosinusitis. Many are not candidates for surgery and either find incomplete relief with classic medications or are unwilling to use long-term medications because of potential side effects. For the current study, we recruited subjects from a population in this category. In effect, the entire group of patients had the following features: 1) all had persistent symptoms not relieved by topical nasal steroids, decongestants, antihistamines, and antibiotics; 2) none of the patients had clear endoscopic or CT evidence of abnormalities that would have warranted surgical intervention.
Different kinds of solutions and methods of nasal irrigation have been described in the past. Physiological saline (normal saline, 0.9% NS), lactated Ringer's solution (LR), and various concentrations of hypertonic saline have been used with varying results. 6 -8 Isotonic saline nasal washing is one of the oldest methods used effectively in the treatment of sinusitis and allergic rhinitis for decades. It is cheap and easy to prepare. Proponents of isotonic nasal irrigation have argued that isotonic saline is better than hypertonic saline based on potential negative aspects of hypertonic saline such as the histamine release, which occurs in response to hypertonic saline challenge, which further leads to nasal hyperreactivity and hypersecretion. In contrast, isotonic saline does not have this adverse effect. In addition, hypertonic saline leads to substance P release and glandular secretion by means of stimulation of nociceptive nerves; hence, there can be pain in patients using hypertonic saline.
The benefits of hypertonic saline, on the other hand, have been reported and documented by many studies. Various authors have demonstrated that hypertonic saline has mucolytic properties. 9,10 Talbot et al. demonstrated that hypertonic saline, in contrast to normal saline, showed a reduction in mucociliary transit time and thereby improved mucociliary clearance. The rheological alterations caused by hypertonic saline were suggested to be the most important factor for improving mucociliary clearance. It is believed that acidic milieu may cause mucous to be in a "gel" or "viscous" phase (gel phase is a semisolid system in which particles are in a more solid form), whereas an alkaline environment causes the mucous to be in a "sol" phase (sol phase is a fluid colloidal system in which the continuous phase is a liquid). 11 Hypertonic saline is a mildly alkaline solution; hence, it keeps the mucous in sol phase and thereby reduces the mucociliary transit time.
Clinical studies also demonstrate that the use of hypertonic saline irrigation for 3 to 6 weeks in patients with rhinosinusitis made significant improvements in 70% of the patients. 5 There were improvements both in subjective symptoms and in the quality-of-life questionnaire (QOL; SF-36) when comparing pretreatment scores with the posttreatment QOL scores. 5 Studies have also reported that 38% of patients who used hypertonic nasal saline irrigation decreased or completely eliminated other nasal medications (such as nasal steroids, antihistamines, and so on) that were taken in addition for symptomatic relief. 5 The concept of replacing hypertonic saline irrigation with hypertonic DSS is based on the therapeutic value of DSS solution as an antiinflammatory agent in the treatment of various dermatologic conditions. Dead Sea salt solution has demonstrated a tremendous response in al- lergic dermatitis, atopic dermatitis, and psoriatic dermatitis. [12] [13] [14] The presence of a high mineral content in the DSS solution has been suggested as the cause of its effect. The various minerals (such as Ca, K, Br, Zn, and especially magnesium salts) are known to exhibit favorable effects in the treatment of inflammatory diseases. 14 It has been proven in various studies that bathing the skin in the Dead Sea or in simulated DSS solutions significantly demonstrates antiinflammatory properties, which also influence epidermal proliferation, differentiation, and enhanced repair. 12 Because we felt hypertonic solutions had better efficacy than isotonic solutions, we used a hypertonic mixture in both experimental and control arms in our study. We used a 1.8% DSS solution in the experimental arm, and our results showed a significant improvement (95.5% and 100%) in terms of nasal symptoms and in rhinitis-related QOL. On the other hand, the control arm (which used 1.8% hypertonic saline) demonstrated only a 60% improvement in nasal symptom scores and a 40% improvement in rhinitis-related QOL. This moderate level of improvement in the control group is of no surprise because of the various theories that have described the benefits of hypertonic saline irrigation in literature. However, the significant improvement noted in the DSS group may possibly be explained by its antiinflammatory effect on the nasal mucosa.
Although the exact reason why the DSS group performed better than the hypertonic saline group is not known, we suggest the following hypothesis: Hypertonic saline irrigation, although effective, has proinflammatory properties that induce mucus and cause hypersecretion. 10 The DSS solution, on the other hand, has an antiinflammatory effect. This, in addition to the other benefits of hypertonic solutions, should explain its edge over the other group.
CONCLUSIONS
The salt and mineral content of the Dead Sea has been purported as having antiinflammatory effects. Nasal irrigation using hypertonic (1.8 N) DSS solution was tested against hypertonic (1.8 N) saline solution to treat symptoms of rhinosinusitis in a double-blind, randomized, controlled study. The results present Level I clinically based evidence that DSS solution is superior to saline in reduction of symptoms and improvement of the quality of life based on the RQLQ(S) survey.
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